ProQR Therapeutics N.V. is a biotech company focused on developing RNA-based therapeutics for genetic diseases. With a strategic pipeline of innovative drugs and a strong commitment to research, they aim to bring hope to patients suffering from conditions such as cystic fibrosis and Leber’s congenital amaurosis.
